Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.
Clinical trial NCT06787976 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06787976
- Sponsor
- Instituto Mexicano del Seguro Social
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-19
- Primary completion
- 2025-12-21
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.